The opposite effect of tapinarof between IMQ and IL-23 induced psoriasis mouse models

被引:1
|
作者
Zhu, Xingyu [1 ,2 ]
Han, Ruomei [1 ]
Tian, Xiaoxue [3 ]
Hochgerner, Mathias [3 ]
Li, Hui [4 ]
Wang, Jiucun [1 ,3 ,5 ]
Xia, Jingjing [1 ,3 ]
机构
[1] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China
[2] Fudan Univ, Inst Six Sect Econ, Shanghai, Peoples R China
[3] Fudan Univ, Greater Bay Area Inst Precis Med Guangzhou, Sch Life Sci, Shanghai, Peoples R China
[4] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai, Peoples R China
[5] Chinese Acad Med Sci, Res Unit Dissecting Populat Genet & Dev New Techno, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
imiquimod; interleukin-23; psoriasis; tapinarof; SKIN INFLAMMATION; DOUBLE-BLIND; MICE;
D O I
10.1111/exd.14862
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Tapinarof is an aryl hydrocarbon receptor (AHR) ligand which is used to treat plaque psoriasis in adults. However, the underlying mechanism is not yet fully understood. In this study, we applied two of the most studied psoriasis mouse models: topical application of imiquimod (IMQ) and subcutaneous injection of IL-23. Although both models successfully induced psoriasis-like lesions in mice, tapinarof had a completely opposite effect on the two models. Tapinarof decreased the expression of multiple essential cytokines involved in the pathological IL-23/IL-17/IL-22 axis and ameliorated IMQ-induced psoriatic dermatitis, inhibiting keratinocyte proliferation and abnormal differentiation. However, in the IL-23-injection-model, tapinarof instead aggravated the disease. Here, tapinarof increased epidermal thickness and differentiated epidermal dysplasia in mice. Our data suggest that tapinarof may have different effects on varied types of psoriasis.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] IL-36y is a strong inducer of IL-23 production and angiogenesis in psoriasis
    Bridgewood, C.
    Fearnley, G.
    Keszegpal, A.
    Laws, P.
    Ponnambalam, S.
    Graham, A.
    Stacey, M.
    Wittmann, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S246 - S246
  • [42] Selective Il-23 Inhibitors: The New Kids on the Block in the Treatment of Psoriasis
    Torres, T.
    ACTAS DERMO-SIFILIOGRAFICAS, 2018, 109 (08): : 674 - 676
  • [43] IL-23 induced signaling and IL-23 receptor expression in human CD4 T cells
    Mat, Nor Fazila Che
    Guzzo, Christina
    Gee, Katrina
    CYTOKINE, 2009, 48 (1-2) : 108 - 108
  • [44] Increased IL-23 Expression in Palmoplantar Psoriasis and Hyperkeratotic Hand Dermatitis
    Lillis, Joseph V.
    Guo, Chang-Sheng
    Lee, Jennifer J.
    Blauvelt, Andrew
    ARCHIVES OF DERMATOLOGY, 2010, 146 (08) : 918 - 919
  • [45] Role of IL-23 in the pathogenesis of psoriasis: a novel potential therapeutic target?
    Chiricozzi, Andrea
    Saraceno, Rosita
    Chimenti, Maria Sole
    Guttman-Yassky, Emma
    Krueger, James G.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (05) : 513 - 525
  • [46] Granzyme K promotes IL-23 secretion and keratinocyte proliferation in psoriasis
    Richardson, K.
    Turner, C.
    Aubert, A.
    Hiroyasu, S.
    Crawford, R.
    Burleigh, A.
    Pawluk, M.
    Nabai, L.
    Jung, K.
    Granville, D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S4 - S4
  • [47] Comparison of IL-23 models of psoriasiform dermatitis in mice
    Su, Z.
    Gauvin, D.
    Wetter, J.
    Salte, K.
    Gerstein, C.
    Leys, L.
    Huang, S.
    Shaughn, B.
    Waegell, W.
    Edlmayer, R.
    Scott, V.
    Honore, P.
    McGaraughty, S.
    Gauld, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S94 - S94
  • [48] Clinical and biological analysis of IL-12, IL-23, TNF-α and IL-17 specific targeting in mouse model of psoriasis
    Caillot, Frederique
    Rizova, Elena
    Benson, Jacqueline
    Musette, Philippe
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S55 - S55
  • [49] Attenuated dynamic of IMQ-induced psoriasis in inflammasomes KO mice models
    Sundnes, O.
    Tveita, A.
    Haraldsen, G.
    Khnykin, D.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 : 39 - 40
  • [50] Effect of HBV-induced IL-23 on the biological behavior of hepatocarcinoma cells
    Jiang, Q.
    Ma, S.
    Guo, Z.
    He, Q.
    Sun, Y.
    Zhu, H.
    Chen, R.
    Ning, Q.
    Cai, X.
    Lei, P.
    Shen, G.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 686 - 687